Atlas Trials

Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma

Clinical trial NCT00151203 · COMPLETED

Trial details

NCT number
NCT00151203
Sponsor
Weill Medical College of Cornell University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2004-12-01
Primary completion
2007-04-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.